Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance
- 1 November 2007
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Rheumatology
- Vol. 19 (6), 523-529
- https://doi.org/10.1097/bor.0b013e3282f01a8c
Abstract
Idiopathic inflammatory myopathy is characterized by the production of autoantibodies to various cellular constituents. These autoantibodies closely correlate with certain clinical conditions and prognosis of disease. This review examines recent progress in myositis-specific autoantibodies, particularly in their clinical significance and pathophysiological roles. During the 1-year review period, novel myositis-specific autoantibodies were identified in clinically amyopathic dermatomyositis (anti-CADM-140 antibody) and malignancy-associated myositis (anti-p155 and anti-p155/p140 antibodies). These new autoantibodies are extremely important because it is thought that myositis-specific autoantibodies are negative in these subgroups, and may enable a new classification of idiopathic inflammatory myopathy. New clinical aspects of other myositis-specific autoantibodies (anti-aminoacyl-tRNA synthetases, anti-signal recognition particles and anti-Mi-2) are also described. The possibility was raised that the high expression of myositis-specific autoantigens in regenerating muscle cells and certain cancers may be involved in initiating and perpetuating the autoimmune response in myositis. Myositis-specific autoantibodies are useful markers for clinical diagnosis, classification and predicting prognosis of idiopathic inflammatory myopathy. To understand the etiopathogenic mechanisms of the disease it is particularly important to elucidate the nature of target autoantigens recognized by these myositis-specific autoantibodies.Keywords
This publication has 52 references indexed in Scilit:
- Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodiesRheumatology, 2007
- Clinical and immunogenetic features of patients with autoantibodies to asparaginyl–transfer RNA synthetaseArthritis & Rheumatism, 2007
- Anti-signal recognition particle autoantibodies: marker of a necrotising myopathyAnnals Of The Rheumatic Diseases, 2006
- A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): A missing link within the spectrum of the idiopathic inflammatory myopathiesJournal of the American Academy of Dermatology, 2006
- Opioid use by patients in an orthopedics spine clinicArthritis & Rheumatism, 2005
- Idiopathic Inflammatory Myopathy with Diffuse Alveolar DamageClinical Rheumatology, 2002
- Structures targeted by the immune system in myositisCurrent Opinion in Rheumatology, 1996
- Two forms of the major antigenic protein of the dermatomyositis‐specific Mi‐2 autoantigenArthritis & Rheumatism, 1996
- Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase.JCI Insight, 1993
- Sequence homology between encephalomyocarditis virus protein VPI and histidyl-tRNA synthetase supports a hypothesis of molecular mimicry in polymyositisMedical Hypotheses, 1988